Solas BioVentures

Francis Medical is a medical technology company focused on developing innovative therapeutic solutions for prostate, kidney, and bladder cancer. The company employs a novel water vapor technology that utilizes thermal energy from sterile water vapor to ablate cancerous tissue through a minimally invasive transurethral procedure. This approach aims to effectively treat endourological cancers while minimizing the life-altering side effects often associated with conventional treatments. By harnessing the energy stored in small amounts of water, Francis Medical seeks to enhance treatment efficacy and protect surrounding healthy structures, offering patients a potentially safer alternative in cancer care.

Vektor Medical, based in San Diego, focuses on transforming arrhythmia care for individuals suffering from atrial fibrillation and other related conditions. The company has developed an advanced, non-invasive technology called vMap, which utilizes artificial intelligence for the analysis and mapping of cardiac arrhythmias. This solution employs computational modeling alongside the patient's electrocardiogram to accurately identify sources of arrhythmias, including both focal and fibrillation types. Vektor Medical's FDA-cleared technology enhances the efficiency of cardiac ablation procedures, optimizes clinical workflows, and ultimately aims to improve patient outcomes in arrhythmia management.

Basking Biosciences is a startup focused on developing a reversible thrombolytic therapy aimed at restoring blood flow to the brain during ischemic strokes, thereby preventing hemorrhage and minimizing long-term damage. The company’s innovative approach involves a paired therapy that combines an active agent targeting a crucial component of clot stability with a designed reversal agent. This reversal agent can be administered if bleeding occurs, effectively neutralizing the active compound and restoring the blood's normal clotting ability. By enabling healthcare professionals to treat acute ischemic stroke effectively, Basking Biosciences aims to improve patient outcomes in critical medical situations.

Arrivo BioVentures LLC is a biopharmaceutical company based in Morrisville, North Carolina, established in 2015. The company specializes in the development of biologics and small molecules aimed at enhancing patient care. Arrivo BioVentures focuses on reformulating existing drugs and creating new chemical entities, employing its expertise to navigate regulatory strategies that streamline the approval process. By collaborating closely with regulatory bodies such as the FDA, the company aims to minimize unexpected challenges and accelerate the implementation of its clinical programs. Through its innovative approach, Arrivo BioVentures seeks to meet the demands of the biotechnology sector while prioritizing the improvement of patient outcomes.

Dimension Inx Corp. focuses on designing and developing three-dimensional (3D) printable materials and painted objects for research and commercial applications. The company specializes in creating regenerative microenvironments that aid the body in self-healing. Its biomaterials platform incorporates a complex interplay of material composition, microstructure, and microarchitecture to enhance biofunctionality. Dimension Inx offers a range of products, including Hyperelastic Bone for bone regeneration, 3D printable elastomers, bioactive ceramics, and solutions for soft tissue regeneration. Founded in 2016 and based in Chicago, Illinois, the company aims to provide innovative therapeutic products that restore tissue and organ function, potentially reducing the need for organ transplantation through advanced bio-fabrication processes.

EirSystems Inc. is a medical software company based in Chattanooga, Tennessee, founded in 2018. It specializes in developing blockchain-based technologies aimed at addressing prescription abuse, specifically through its Prescription Abuse Greatly Reduced (P.A.G.R.) platform. This innovative system enables doctors and pharmacists to accurately track opioid prescriptions, manage the prescribing process, and perform medication reconciliation. By employing distributed ledger technology, EirSystems enhances efficiency and interoperability within healthcare services, allowing clients to effectively oversee and monitor prescription medicines.

Stimdia Medical specializes in the development of a non-invasive lung pacing device aimed at facilitating the weaning of patients from mechanical ventilation. This innovative device significantly decreases the time required for patients to transition off ventilators, thereby enhancing patient outcomes and minimizing associated health risks. By streamlining this process, Stimdia Medical also contributes to substantial cost savings for healthcare providers, making it a valuable addition to critical care practices.

Pathware Inc. specializes in developing automated point-of-care biopsy assessment systems aimed at enhancing the diagnostic capabilities of clinicians and pathologists. Its flagship product, Bioptic, allows for the rapid diagnosis of pathogens, while its sample management platform streamlines the pathology workflow by minimizing repetitive tasks. The company’s digital pathology platform integrates advanced hardware and software tools, facilitating immediate analysis of tissue samples at the point of care, thereby reducing the need to send samples to central laboratories. This innovation significantly shortens turnaround times and improves patient care through AI-powered image analysis and telepathology capabilities. Founded in 2017 and headquartered in Ann Arbor, Michigan, with an additional location in Seattle, Washington, Pathware is dedicated to improving healthcare by leveraging computational microscopy and artificial intelligence for more accurate and timely disease diagnosis and treatment.

CryOSA is a medical device company focused on developing innovative treatments for obstructive sleep apnea. The company creates devices aimed at assisting patients with sleep-disordered breathing, particularly those experiencing moderate to severe forms of this condition. By addressing the challenges associated with obstructive sleep apnea, CryOSA seeks to improve the quality of life for individuals affected by this disorder.

Francis Medical is a medical technology company focused on developing innovative therapeutic solutions for prostate, kidney, and bladder cancer. The company employs a novel water vapor technology that utilizes thermal energy from sterile water vapor to ablate cancerous tissue through a minimally invasive transurethral procedure. This approach aims to effectively treat endourological cancers while minimizing the life-altering side effects often associated with conventional treatments. By harnessing the energy stored in small amounts of water, Francis Medical seeks to enhance treatment efficacy and protect surrounding healthy structures, offering patients a potentially safer alternative in cancer care.

InterShunt is a medical device company based in St. Louis, Missouri, founded in 2015. The company specializes in designing and developing a proprietary catheter-based system aimed at alleviating the symptoms of heart failure. Their innovative approach centers on left atrial decompression, utilizing a minimally invasive procedure that does not require any implants or energy for capturing and excising tissue from the interatrial septum. By enabling healthcare professionals to effectively reduce left atrial pressure, InterShunt seeks to provide significant relief for millions of individuals suffering from heart failure.

Knopp Biosciences LLC is a biotech company based in Pittsburgh, Pennsylvania, established in 2004. The company is dedicated to discovering and developing innovative medicines for inflammatory and neurological diseases. Its product portfolio includes dexpramipexole, an anti-inflammatory therapeutic aimed at modulating white blood cells, alongside a hematology discovery program focused on selectively arresting eosinophil maturation to treat inflammatory conditions. Knopp also has a preclinical KCNQ2 program targeting a genetic mutation linked to neonatal encephalopathy and related disorders, as well as a mitochondrial discovery initiative that seeks small molecule modulators to enhance mitochondrial efficiency. By focusing on diseases that impose significant burdens on the healthcare system and utilizing validated biomarkers and genetic testing, Knopp Biosciences aims to accelerate treatment development and improve patient outcomes.

BioStable Science & Engineering, Inc. is a cardiovascular device company based in Austin, Texas, that specializes in developing valve repair technologies as alternatives to valve replacement for patients with aortic valve disease. The company offers a range of HAART aortic valve repair technologies, including the HAART 300 aortic annuloplasty device, designed to reduce annular dilatation and restore three-dimensional annular geometry, and the HAART 200 device tailored for bicuspid aortic valve repair. Additionally, BioStable's aortic root restoration system aims to enhance surgical outcomes for patients with aortic insufficiency or aortic root aneurysm. Founded in 2008, BioStable leverages its expertise in product development, regulatory affairs, and clinical validation to minimize time to market for its innovative medical devices, ultimately improving patient care in the cardiovascular field.

AEGEA Medical, Inc. is a medical technology company based in Menlo Park, California, focused on improving women's healthcare through innovative treatment options. The company has developed a water vapor ablation system, known as Mara, which provides a safe and effective method for endometrial ablation to treat heavy menstrual bleeding, or menorrhagia. This FDA-approved technology allows for a straightforward, office-based procedure that typically takes only minutes to perform. AEGEA is dedicated to enhancing patient outcomes and expanding access to effective therapies, while also supporting physicians in delivering these procedures with confidence and ease. Founded in 2008, AEGEA Medical is committed to pioneering advancements in women’s health.

AEGEA Medical, Inc. is a medical technology company based in Menlo Park, California, focused on improving women's healthcare through innovative treatment options. The company has developed a water vapor ablation system, known as Mara, which provides a safe and effective method for endometrial ablation to treat heavy menstrual bleeding, or menorrhagia. This FDA-approved technology allows for a straightforward, office-based procedure that typically takes only minutes to perform. AEGEA is dedicated to enhancing patient outcomes and expanding access to effective therapies, while also supporting physicians in delivering these procedures with confidence and ease. Founded in 2008, AEGEA Medical is committed to pioneering advancements in women’s health.

ATFX is a prominent Forex CFD broker that offers a diverse selection of over 300 trading products, including forex currency pairs, commodities such as precious metals and crude oil, indices, and stocks. With a global presence that spans 21 offices across regions including Europe, South America, the Middle East, Asia, Australia, and South Africa, ATFX aims to provide a comprehensive and user-friendly trading experience. The company has earned a strong reputation, reflected in its receipt of more than 80 international awards for excellence in online trading and customer service, including titles such as 'Best Fintech Forex Broker' and 'Global Forex Broker of the Year.' ATFX is recognized for its innovative online broking services platform, which facilitates seamless transactions and offers access to a variety of trading tools and resources, catering to the needs of online traders in the financial markets.

PreTel is a Canadian company specializing in the development of fetal monitoring systems aimed at enhancing maternal and pediatric outcomes during labor and delivery. The company focuses on uterine electromyography (uEMG) monitoring and area sensor solutions, which address the challenges of accurately distinguishing between true and false labor. This innovation helps reduce unnecessary invasive monitoring, cesarean deliveries, and costly neonatal intensive care stays. PreTel's sensors are designed to assess all stages of pregnancy by identifying independent contraction activity in different regions of the uterus. This capability allows healthcare providers to manage preterm labor more effectively and ensure safer delivery processes, ultimately improving care for both mothers and newborns.

Arrivo BioVentures LLC is a biopharmaceutical company based in Morrisville, North Carolina, established in 2015. The company specializes in the development of biologics and small molecules aimed at enhancing patient care. Arrivo BioVentures focuses on reformulating existing drugs and creating new chemical entities, employing its expertise to navigate regulatory strategies that streamline the approval process. By collaborating closely with regulatory bodies such as the FDA, the company aims to minimize unexpected challenges and accelerate the implementation of its clinical programs. Through its innovative approach, Arrivo BioVentures seeks to meet the demands of the biotechnology sector while prioritizing the improvement of patient outcomes.

ATFX is a prominent Forex CFD broker that offers a diverse selection of over 300 trading products, including forex currency pairs, commodities such as precious metals and crude oil, indices, and stocks. With a global presence that spans 21 offices across regions including Europe, South America, the Middle East, Asia, Australia, and South Africa, ATFX aims to provide a comprehensive and user-friendly trading experience. The company has earned a strong reputation, reflected in its receipt of more than 80 international awards for excellence in online trading and customer service, including titles such as 'Best Fintech Forex Broker' and 'Global Forex Broker of the Year.' ATFX is recognized for its innovative online broking services platform, which facilitates seamless transactions and offers access to a variety of trading tools and resources, catering to the needs of online traders in the financial markets.

PreTel is a Canadian company specializing in the development of fetal monitoring systems aimed at enhancing maternal and pediatric outcomes during labor and delivery. The company focuses on uterine electromyography (uEMG) monitoring and area sensor solutions, which address the challenges of accurately distinguishing between true and false labor. This innovation helps reduce unnecessary invasive monitoring, cesarean deliveries, and costly neonatal intensive care stays. PreTel's sensors are designed to assess all stages of pregnancy by identifying independent contraction activity in different regions of the uterus. This capability allows healthcare providers to manage preterm labor more effectively and ensure safer delivery processes, ultimately improving care for both mothers and newborns.

AEGEA Medical, Inc. is a medical technology company based in Menlo Park, California, focused on improving women's healthcare through innovative treatment options. The company has developed a water vapor ablation system, known as Mara, which provides a safe and effective method for endometrial ablation to treat heavy menstrual bleeding, or menorrhagia. This FDA-approved technology allows for a straightforward, office-based procedure that typically takes only minutes to perform. AEGEA is dedicated to enhancing patient outcomes and expanding access to effective therapies, while also supporting physicians in delivering these procedures with confidence and ease. Founded in 2008, AEGEA Medical is committed to pioneering advancements in women’s health.